Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
EVH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.06 - $33.63
Previous CloseN/A
Volume268.11K
Average Volume (3M)2.52M
Market Cap
$1.03B
Enterprise Value$2.21B
Total Cash (Recent Filing)$151.00M
Total Debt (Recent Filing)$204.74M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Oct 29, 2025EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding117,508,720
10 Day Avg. Volume2,460,318
30 Day Avg. Volume2,516,324
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.14
Enterprise Value/Revenue1.01
Enterprise Value/Gross Profit6.58
Enterprise Value/Ebitda209.48
Forecast
1Y Price Target
$14.89Price Target Upside68.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceEvolent Health beat second quarter estimates and raised its 2025 adjusted EBITDA guidance.
Financial StabilityThe company has secured financing to maintain a healthy cash position and support new business ventures, providing financial stability.
Pipeline GrowthThere is strength in EVH’s pipeline, with four new revenue arrangements signed this quarter.
Bears Say
Earnings ReportEvolent Health reported somewhat mixed second quarter 2025 earnings, with revenue coming in toward the low end of guidance and modestly below the Street.
Quarterly RevenueRevenue fell 8% quarter-over-quarter, missing expectations largely due to a delay in a PS contract.
Revenue GuidanceRevenue guidance was lowered by $220M due to two PS delays, including a contract delay with AET.
Evolent Health News
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $7.06 and its highest was $33.63 in the past 12 months.
What is Evolent Health’s market cap?
Evolent Health’s market cap is $1.03B.
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Oct 29, 2025 which is in 75 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Aug 07, 2025. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of $0.074 by -$0.174.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is 0.11.
How many shares outstanding does Evolent Health have?
Evolent Health has 117,508,720 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of -$0.1 in its last earnings report, missing expectations of $0.074. Following the earnings report the stock price went down -7.121%.
Which hedge fund is a major shareholder of Evolent Health?
Currently, no hedge funds are holding shares in EVH
Evolent Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.89 (68.82% Upside)
$14.89 (68.82% Upside)
Blogger Sentiment
Bullish
EVH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 3.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.82%
12-Months-Change
Fundamentals
Return on Equity
-13.38%
Trailing 12-Months
Asset Growth
-0.55%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health (EVH) is a leading healthcare technology company that specializes in providing integrated solutions to health systems and payers. The company operates in the healthcare sector, focusing on value-based care models aimed at improving patient outcomes and reducing costs. Evolent Health offers a suite of services including care management, analytics, technology infrastructure, and population health management, enabling healthcare organizations to transition to value-based care while enhancing operational efficiencies.
EVH Company Deck
EVH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call contained a mix of positive developments such as strong EBITDA performance, new partnerships, and a robust pipeline, but also highlighted challenges including revised revenue guidance, high oncology trends, and cash flow issues. The sentiment is balanced between optimism for future growth and caution due to current challenges.View all EVH earnings summariesEVH Stock 12 Month Forecast
Average Price Target
$14.89
▲(68.82% Upside)
Technical Analysis
Ownership Overview
2.20% Insiders
33.70% Mutual Funds
0.73% Other Institutional Investors
47.95% Public Companies and
Individual Investors